<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebroprotection after administration of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> has been well documented </plain></SENT>
<SENT sid="1" pm="."><plain>The present study is intended to determine whether the non-competitive alpha-amino-3-hydroxy-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-isoxazolyl-<z:chebi fb="0" ids="30768">propionic acid</z:chebi> (AMPA) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> talampanel, known as <z:chebi fb="0" ids="35623">antiepileptic</z:chebi> drug, has neuroprotective effects in <z:hpo ids='HP_0001297'>stroke</z:hpo> models in rodents </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> size was measured in three models of <z:hpo ids='HP_0001297'>stroke</z:hpo> by 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="3" pm="."><plain>Therapeutic time window was also examined in rats subjected to 1h middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The degree of neuroprotection was tested in mice, using 1.5, 2 h or permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusions</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Effect on photochemically induced <z:mp ids='MP_0005048'>thrombosis</z:mp> was investigated in rats applying 30 min time window after brain irradiation </plain></SENT>
<SENT sid="6" pm="."><plain>Talampanel reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size by 47.3% (p&lt;0.01) after a 30 min delay and 48.5% (p&lt;0.01) after 2 h delay following middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in rats </plain></SENT>
<SENT sid="7" pm="."><plain>In mice, talampanel reduced the extension of the infarcted tissue at the levels of striatum and hippocampus by 44.5% (p&lt;0.05) and 39.3% (p&lt;0.01) after 1.5 h <z:e sem="disease" ids="C0022118" disease_type="Disease or Syndrome" abbrv="">transient ischemia</z:e> and still caused 37.0% (p&lt;0.05) and 37.0% (p&lt;0.05) inhibitions when 2 h occlusion was applied </plain></SENT>
<SENT sid="8" pm="."><plain>In photothrombosis talampanel showed a 40.1% (p&lt;0.05) inhibition </plain></SENT>
<SENT sid="9" pm="."><plain>Protective actions of talampanel in various <z:hpo ids='HP_0001297'>stroke</z:hpo> models, in rats and mice, suggest a possible therapeutic role of the compound in <z:hpo ids='HP_0001297'>stroke</z:hpo> patients </plain></SENT>
</text></document>